The decrease of cisplatin resistance in ovarian cancer cells by curcumin is probably through regulating extracellular vesicle-induced transfer of miR-214 and maternally expressed 3 (MEG3) [100]. The gene discussed is MEG3; the disease is ovarian cancer.